Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma
Public ClinicalTrials.gov record NCT00051987. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Open-Label, Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma
Study identification
- NCT ID
- NCT00051987
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Millennium Pharmaceuticals, Inc.
- Industry
- Enrollment
- 175 participants
Conditions and interventions
Conditions
Interventions
- VELCADE TM (bortezomib) for Injection, or PS-341 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2002
- Primary completion
- Feb 29, 2004
- Completion
- Not listed
- Last update posted
- Feb 10, 2008
Started 2002
United States locations
- U.S. sites
- 22
- U.S. states
- 18
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cooper Green Hospital / Jefferson Clinic P.C. | Birmingham | Alabama | 35233 | — |
| Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| Arkansas Cancer Center | Pine Bluff | Arkansas | 71603 | — |
| Alta Bates Comprehensive Cancer Center | Berkley | California | 94704 | — |
| California Cancer Center | Greenbrae | California | 94904 | — |
| USC/Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| City of Hope Medical Group | Pasadena | California | 91105 | — |
| H. Lee Moffit Cancer Center | Tampa | Florida | 33612 | — |
| Rush Cancer Institute | Chicago | Illinois | 60612 | — |
| Kentuckiana Cancer Institute, PLLC | Louisville | Kentucky | 40202 | — |
| West Michigan Regional Cancer and Blood Center | Ludington | Michigan | 49431 | — |
| Bond Clinic Inc. | Rolla | Missouri | 65402 | — |
| Nevada Cancer Center | Las Vegas | Nevada | 89109 | — |
| Norris Cotton Cancer Center | Lebanon | New Hampshire | 03756 | — |
| The Cancer Institute of New Jersey | New Brunswick | New Jersey | 08901 | — |
| New York University | New York | New York | 10016 | — |
| St. Lukes Rossevelt Hospital | New York | New York | 10019 | — |
| UNC School of Medicine | Chapel Hill | North Carolina | 27599 | — |
| Ohio State University Medical Center | Columbus | Ohio | 43210 | — |
| Oregon Health Sciences | Portland | Oregon | 97201 | — |
| Memphis Cancer Center, PC | Memphis | Tennessee | 38119 | — |
| University of Texas Health Sciences Center at San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00051987, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 10, 2008 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00051987 live on ClinicalTrials.gov.